Success Metrics

Clinical Success Rate
57.1%

Based on 8 completed trials

Completion Rate
57%(8/14)
Active Trials
7(25%)
Results Posted
38%(3 trials)
Terminated
6(21%)

Phase Distribution

Ph phase_3
3
11%
Ph phase_4
5
18%
Ph phase_2
2
7%
Ph not_applicable
17
61%

Phase Distribution

0

Early Stage

2

Mid Stage

8

Late Stage

Phase Distribution27 total trials
Phase 2Efficacy & side effects
2(7.4%)
Phase 3Large-scale testing
3(11.1%)
Phase 4Post-market surveillance
5(18.5%)
N/ANon-phased studies
17(63.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

53.3%

8 of 15 finished

Non-Completion Rate

46.7%

7 ended early

Currently Active

7

trials recruiting

Total Trials

28

all time

Status Distribution
Active(9)
Completed(8)
Terminated(7)
Other(4)

Detailed Status

Completed8
Terminated6
Recruiting4
unknown3
Active, not recruiting3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
28
Active
7
Success Rate
57.1%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (7.4%)
Phase 33 (11.1%)
Phase 45 (18.5%)
N/A17 (63.0%)

Trials by Status

not_yet_recruiting27%
completed829%
recruiting414%
withdrawn14%
terminated621%
unknown311%
suspended14%
active_not_recruiting311%

Recent Activity

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more
NCT04097145Not Applicable

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Recruiting
NCT04482062Not Applicable

TRISCEND II Pivotal Trial

Active Not Recruiting
NCT03563417Not Applicable

ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO

Recruiting
NCT05806138Phase 2

A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction

Active Not Recruiting
NCT02845531Phase 4

Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death

Recruiting
NCT05118269Not Applicable

A Randomized Controlled Trial of InterVapor® in France - The TARGET Trial

Terminated
NCT02121158Not Applicable

Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly

Terminated
NCT03052036Not Applicable

The British Heart Foundation SENIOR-RITA Trial

Active Not Recruiting
NCT06458907Not Applicable

TRICAV-II Pivotal: TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation.

Not Yet Recruiting
NCT06075823Not Applicable

Edge-to-edge Mitral Valve Repair in ATTR-CM

Not Yet Recruiting
NCT04606459Not Applicable

COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina

Recruiting
NCT00119847Not Applicable

Electrophysiological Effects of Late PCI After MI

Completed
NCT04808661Not Applicable

EndovaScular Versus mediCaL mAnagement of Uncomplicated Type B Intramural heMatoma Trial (ESCLAIM)

Unknown
NCT03071653Phase 2

Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study

Suspended
NCT00074724Not Applicable

Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization

Completed
NCT02857309Not Applicable

Cardiac Contractility Modulation (CCM) Therapy in Subjects With Medically Refractory Heart Failure

Terminated
NCT02964975Phase 4

Randomized Comparison of Optimal Medical Therapy and Percutaneous Recanalization for Chronic Total Occlusion (COMET-CTO)

Completed
NCT02985268Not Applicable

Evaluation of Outcomes of CRT and MitraClip for Treatment of Low Ejection Fraction and Functional Mitral Regurgitation in HF

Withdrawn
NCT04111744Not Applicable

Preoperative Excercise Training for Patients Undergoing Coronary Artery Bypass Graft Surgery

Completed
NCT01078051Phase 4

Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
28